安定同位体標識化合物の世界市場、化合物別(炭素(13C)、窒素(15N)、重水素、酸素(18O)、その他)、用途別(診断、創薬、イメージング、滅菌、その他)、物質別(核酸、アミノ酸、医薬品/代謝物、脂肪酸/脂質、その他)、適応症別(循環器、神経、炎症、代謝性疾患、その他)、測定方法別(化学、細胞培養、その他)、エンドユーザー別(医薬品、医療機器、その他)。NMR溶媒、その他)、適応症(循環器、神経、炎症、代謝性疾患、その他)、方法(化学、細胞培養)、エンドユーザー(製薬・バイオテクノロジー企業、学術機関、その他)、地域別、2025年の予測および機会、その他Global Stable Isotope Labeled Compounds Market, By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others), By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others), By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others), By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others), By Method (Chemical, Cell-culturing), By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others), By Region, Forecast & Opportunities, 2025 安定同位体標識化合物の世界市場は、予測期間中に安定した CAGR で成長すると予想されます。これらの化合物は、化学代謝中の同位体経路を確認したり、細胞内の任意の同位体の存在を検出したりするために使用され... もっと見る
サマリー安定同位体標識化合物の世界市場は、予測期間中に安定した CAGR で成長すると予想されます。これらの化合物は、化学代謝中の同位体経路を確認したり、細胞内の任意の同位体の存在を検出したりするために使用されます。したがって、一般的に生物医学研究や研究開発分野で使用され、これが市場成長の主な要因となっています。癌患者の増加や製薬・バイオテクノロジー企業の増加は、市場成長の主要な要因の一つです。しかし、これらの化合物はコストが高いため購入できないことが、市場の抑制要因として働く可能性があります。安定同位体標識化合物の世界市場は、化合物、用途、物質、適応症、手法、エンドユーザー、地域に基づいて区分されます。エンドユーザーセグメントは、さらに製薬・バイオテクノロジー企業、学術機関、その他に細分化され、このうち製薬・バイオテクノロジー企業セグメントは、これらの化合物に基づく研究の増加により、2019年に最も急速に成長すると予測される。 地域別に見ると、世界の安定同位体標識化合物市場は、アジア太平洋、ヨーロッパ、北米、南米、中東・アフリカに区分することができる。2019年現在、北米は、様々な安定同位体ベースの研究企業の存在と、それらの企業で研究開発手順を実行するのに十分な経済性を背景に、最大の市場シェアを占めています。 世界の安定同位体標識化合物市場の主要企業には、PerkinElmer、Merck、3M、Cambridge Isotope Laboratories, Inc、URENCO Limited、IsoSciences LLC、Medical Isotopes, Inc、Omicron Biochemicals, Inc、Trace Sciences International、Alsachim、大日本山荘株式会社、CortecNet、ISOFLEX、Huayi Isotopes Co, Mesbah Energy Co, C/D/N/ Isotope Inc, Shoko Co.Ltd.、Nordion Inc.、BOC Sciences、Pepscan、など。 本レポートで考慮した年数 歴史的年数:2015年~2018年 基準年:2019年 推定年:2020年 予測期間:2021-2025年 本調査の目的 - 世界の安定同位体標識化合物の市場規模を分析・予測する。 - 化合物、用途、物質、適応症、方法、エンドユーザー、地域、企業に基づいて、世界の安定同位体標識化合物市場を分類・予測する。 - 世界の安定同位体標識化合物市場の促進要因と課題を特定する。 - 世界の安定同位体標識化合物市場における拡張、新製品発表、M&Aなどの競合開発を調査する。 - 世界の安定同位体標識化合物市場の価格分析を行う。 - 世界の安定同位体標識化合物市場で活動する主要企業のプロファイルを特定し、分析する。 TechSci Research社は、本調査のために一次調査と徹底的な二次調査の両方を実施しました。最初に、TechSci Researchは世界中のメーカーのリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査アンケートを実施しました。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかったメーカーを含めることができました。TechSci Researchは、世界中のすべての主要企業のメーカー、流通チャネル、存在を分析しました。 TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来の予測を行うボトムアップアプローチを用いて、世界の安定同位体標識化合物の市場規模を算出しました。TechSci Research社は、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品タイプや用途の履歴データを分析することで外部的に検証しています。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。 主な対象読者 - 安定同位体標識化合物メーカー、サプライヤー、流通業者、その他の関係者 - バイオテクノロジーおよび製薬会社 - 規制当局や政策立案者などの政府機関 - 安定同位体標識化合物に関連する組織、フォーラム、アライアンス - 市場調査会社、コンサルティング会社 本調査は、メーカー、パートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、さらに、投資戦略を立て、市場機会を活用する上で有用なものです。 レポートの範囲 本レポートでは、安定同位体標識化合物の世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています。 - 市場、化合物別 o 炭素(13C) o 窒素(15N) o 重水素 o 酸素(18O) o その他 - 市場、アプリケーション別 o 診断 o 創薬 o 画像処理 o 殺菌 o その他 - 市場、物質別 o 核酸 o アミノ酸 o 医薬品/代謝物 o 脂肪酸/脂質 o NMR溶媒 o その他 - 市場、適応症別 o 循環器 o 神経 o 炎症 o 代謝性疾患 o その他 - 市場、方法別 o 化学的手法 o 細胞培養 - 市場、エンドユーザー別 o 製薬会社、バイオテクノロジー会社 o 学術機関 o その他 - 市場、地域別 o アジア太平洋地域 中国 インド 日本 韓国 シンガポール オーストラリア o ヨーロッパ フランス ドイツ イギリス イタリア ロシア スペイン o 北米 米国 メキシコ カナダ o 南アメリカ ブラジル アルゼンチン コロンビア o 中東・アフリカ 南アフリカ サウジアラビア UAE 競合他社の状況 企業プロファイル。世界の安定同位体標識化合物市場における主要企業の詳細分析。 利用可能なカスタマイズ。 TechSci Researchでは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供しています。このレポートでは、以下のカスタマイズが可能です。 企業情報 - 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社)。 目次1. Product Overview2. Research Methodology 3. Executive Summary 4. Voice of Customer 5. Global Stable Isotopes Labeled Compounds Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value & Volume 5.2. Market Share & Forecast 5.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others) 5.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others) 5.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids. NMR Solvents and Others) 5.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others) 5.2.5. By Method (Chemical, Cell-culturing) 5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others) 5.2.7. By Company (2019) 5.2.8. By Region 5.3. Market Attractiveness Index 6. Asia-Pacific Stable Isotopes Labeled Compounds Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value & Volume 6.2. Market Share & Forecast 6.2.1. By Compounds 6.2.2. By Application 6.2.3. By Substances 6.2.4. By Indication 6.2.5. By Method 6.2.6. By End-User 6.2.7. By Country 6.3. Market Attractiveness Index 6.4. Asia-Pacific: Country Analysis 6.4.1. China Stable Isotopes Labeled Compounds Market Outlook 6.4.1.1. Market Size & Forecast 6.4.1.1.1. By Value 6.4.1.2. Market Share & Forecast 6.4.1.2.1. By Compounds 6.4.1.2.2. By Application 6.4.1.2.3. By Substances 6.4.1.2.4. By Indication 6.4.1.2.5. By Method 6.4.1.2.6. By End-User 6.4.2. India Stable Isotopes Labeled Compounds Market Outlook 6.4.2.1. Market Size & Forecast 6.4.2.1.1. By Value 6.4.2.2. Market Share & Forecast 6.4.2.2.1. By Compounds 6.4.2.2.2. By Application 6.4.2.2.3. By Substances 6.4.2.2.4. By Indication 6.4.2.2.5. By Method 6.4.2.2.6. By End-User 6.4.3. Japan Stable Isotopes Labeled Compounds Market Outlook 6.4.3.1. Market Size & Forecast 6.4.3.1.1. By Value 6.4.3.2. Market Share & Forecast 6.4.3.2.1. By Compounds 6.4.3.2.2. By Application 6.4.3.2.3. By Substances 6.4.3.2.4. By Indication 6.4.3.2.5. By Method 6.4.3.2.6. By End-User 6.4.4. South Korea Stable Isotopes Labeled Compounds Market Outlook 6.4.4.1. Market Size & Forecast 6.4.4.1.1. By Value 6.4.4.2. Market Share & Forecast 6.4.4.2.1. By Compounds 6.4.4.2.2. By Application 6.4.4.2.3. By Substances 6.4.4.2.4. By Indication 6.4.4.2.5. By Method 6.4.4.2.6. By End-User 6.4.5. Singapore Stable Isotopes Labeled Compounds Market Outlook 6.4.5.1. Market Size & Forecast 6.4.5.1.1. By Value 6.4.5.2. Market Share & Forecast 6.4.5.2.1. By Compounds 6.4.5.2.2. By Application 6.4.5.2.3. By Substances 6.4.5.2.4. By Indication 6.4.5.2.5. By Method 6.4.5.2.6. By End-User 6.4.6. Australia Stable Isotopes Labeled Compounds Market Outlook 6.4.6.1. Market Size & Forecast 6.4.6.1.1. By Value 6.4.6.2. Market Share & Forecast 6.4.6.2.1. By Compounds 6.4.6.2.2. By Application 6.4.6.2.3. By Substances 6.4.6.2.4. By Indication 6.4.6.2.5. By Method 6.4.6.2.6. By End-User 7. Europe Stable Isotopes Labeled Compounds Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value & Volume 7.2. Market Share & Forecast 7.2.1. By Compounds 7.2.2. By Application 7.2.3. By Substances 7.2.4. By Indication 7.2.5. By Method 7.2.6. By End-User 7.2.7. By Country 7.3. Market Attractiveness Index 7.4. Europe: Country Analysis 7.4.1. France Stable Isotopes Labeled Compounds Market Outlook 7.4.1.1. Market Size & Forecast 7.4.1.1.1. By Value 7.4.1.2. Market Share & Forecast 7.4.1.2.1. By Product 7.4.1.2.2. By Compounds 7.4.1.2.3. By Application 7.4.1.2.4. By Substances 7.4.1.2.5. By Indication 7.4.1.2.6. By Method 7.4.1.2.7. By End-User 7.4.2. Germany Stable Isotopes Labeled Compounds Market Outlook 7.4.2.1. Market Size & Forecast 7.4.2.1.1. By Value 7.4.2.2. Market Share & Forecast 7.4.2.2.1. By Compounds 7.4.2.2.2. By Application 7.4.2.2.3. By Substances 7.4.2.2.4. By Indication 7.4.2.2.5. By Method 7.4.2.2.6. By End-User 7.4.3. United Kingdom Stable Isotopes Labeled Compounds Market Outlook 7.4.3.1. Market Size & Forecast 7.4.3.1.1. By Value 7.4.3.2. Market Share & Forecast 7.4.3.2.1. By Compounds 7.4.3.2.2. By Application 7.4.3.2.3. By Substances 7.4.3.2.4. By Indication 7.4.3.2.5. By Method 7.4.3.2.6. By End-User 7.4.4. Italy Stable Isotopes Labeled Compounds Market Outlook 7.4.4.1. Market Size & Forecast 7.4.4.1.1. By Value 7.4.4.2. Market Share & Forecast 7.4.4.2.1. By Compounds 7.4.4.2.2. By Application 7.4.4.2.3. By Substances 7.4.4.2.4. By Indication 7.4.4.2.5. By Method 7.4.4.2.6. By End-User 7.4.5. Russia Stable Isotopes Labeled Compounds Market Outlook 7.4.5.1. Market Size & Forecast 7.4.5.1.1. By Value 7.4.5.2. Market Share & Forecast 7.4.5.2.1. By Compounds 7.4.5.2.2. By Application 7.4.5.2.3. By Substances 7.4.5.2.4. By Indication 7.4.5.2.5. By Method 7.4.5.2.6. By End-User 7.4.6. Spain Stable Isotopes Labeled Compounds Market Outlook 7.4.6.1. Market Size & Forecast 7.4.6.1.1. By Value 7.4.6.2. Market Share & Forecast 7.4.6.2.1. By Compounds 7.4.6.2.2. By Application 7.4.6.2.3. By Substances 7.4.6.2.4. By Indication 7.4.6.2.5. By Method 7.4.6.2.6. By End-User 8. North America Stable Isotopes Labeled Compounds Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value & Volume 8.2. Market Share & Forecast 8.2.1. By Compounds 8.2.2. By Application 8.2.3. By Substances 8.2.4. By Indication 8.2.5. By Method 8.2.6. By End-User 8.2.7. By Country 8.3. Market Attractiveness Index 8.4. North America: Country Analysis 8.4.1. United States Stable Isotopes Labeled Compounds Market Outlook 8.4.1.1. Market Size & Forecast 8.4.1.1.1. By Value 8.4.1.2. Market Share & Forecast 8.4.1.2.1. By Compounds 8.4.1.2.2. By Application 8.4.1.2.3. By Substances 8.4.1.2.4. By Indication 8.4.1.2.5. By Method 8.4.1.2.6. By End-User 8.4.2. Mexico Stable Isotopes Labeled Compounds Market Outlook 8.4.2.1. Market Size & Forecast 8.4.2.1.1. By Value 8.4.2.2. Market Share & Forecast 8.4.2.2.1. By Compounds 8.4.2.2.2. By Application 8.4.2.2.3. By Substances 8.4.2.2.4. By Indication 8.4.2.2.5. By Method 8.4.2.2.6. By End-User 8.4.3. Canada Stable Isotopes Labeled Compounds Market Outlook 8.4.3.1. Market Size & Forecast 8.4.3.1.1. By Value 8.4.3.2. Market Share & Forecast 8.4.3.2.1. By Compounds 8.4.3.2.2. By Application 8.4.3.2.3. By Substances 8.4.3.2.4. By Indication 8.4.3.2.5. By Method 8.4.3.2.6. By End-User 9. South America Stable Isotopes Labeled Compounds Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value & Volume 9.2. Market Share & Forecast 9.2.1. By Compounds 9.2.2. By Application 9.2.3. By Substances 9.2.4. By Indication 9.2.5. By Method 9.2.6. By End-User 9.2.7. By Country 9.3. Market Attractiveness Index 9.4. South America: Country Analysis 9.4.1. Brazil Stable Isotopes Labeled Compounds Market Outlook 9.4.1.1. Market Size & Forecast 9.4.1.1.1. By Value 9.4.1.2. Market Share & Forecast 9.4.1.2.1. By Compounds 9.4.1.2.2. By Application 9.4.1.2.3. By Substances 9.4.1.2.4. By Indication 9.4.1.2.5. By Method 9.4.1.2.6. By End-User 9.4.2. Argentina Stable Isotopes Labeled Compounds Market Outlook 9.4.2.1. Market Size & Forecast 9.4.2.1.1. By Value 9.4.2.2. Market Share & Forecast 9.4.2.2.1. By Compounds 9.4.2.2.2. By Application 9.4.2.2.3. By Substances 9.4.2.2.4. By Indication 9.4.2.2.5. By Method 9.4.2.2.6. By End-User 9.4.3. Colombia Stable Isotopes Labeled Compounds Market Outlook 9.4.3.1. Market Size & Forecast 9.4.3.1.1. By Value 9.4.3.2. Market Share & Forecast 9.4.3.2.1. By Compounds 9.4.3.2.2. By Application 9.4.3.2.3. By Substances 9.4.3.2.4. By Indication 9.4.3.2.5. By Method 9.4.3.2.6. By End-User 10. Middle East and Africa Stable Isotopes Labeled Compounds Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value & Volume 10.2. Market Share & Forecast 10.2.1. By Compounds 10.2.2. By Application 10.2.3. By Substances 10.2.4. By Indication 10.2.5. By Method 10.2.6. By End-User 10.2.7. By Country 10.3. Market Attractiveness Index 10.4. MEA: Country Analysis 10.4.1. South Africa Stable Isotopes Labeled Compounds Market Outlook 10.4.1.1. Market Size & Forecast 10.4.1.1.1. By Value 10.4.1.2. Market Share & Forecast 10.4.1.2.1. By Compounds 10.4.1.2.2. By Application 10.4.1.2.3. By Substances 10.4.1.2.4. By Indication 10.4.1.2.5. By Method 10.4.1.2.6. By End-User 10.4.2. Saudi Arabia Stable Isotopes Labeled Compounds Market Outlook 10.4.2.1. Market Size & Forecast 10.4.2.1.1. By Value 10.4.2.2. Market Share & Forecast 10.4.2.2.1. By Compounds 10.4.2.2.2. By Application 10.4.2.2.3. By Substances 10.4.2.2.4. By Indication 10.4.2.2.5. By Method 10.4.2.2.6. By End-User 10.4.3. UAE Stable Isotopes Labeled Compounds Market Outlook 10.4.3.1. Market Size & Forecast 10.4.3.1.1. By Value 10.4.3.2. Market Share & Forecast 10.4.3.2.1. By Compounds 10.4.3.2.2. By Application 10.4.3.2.3. By Substances 10.4.3.2.4. By Indication 10.4.3.2.5. By Method 10.4.3.2.6. By End-User 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 13. Competitive Landscape 13.1. Competition Outlook 13.2. Players Profiled (Leading Companies) 13.2.1. PerkinElmer 13.2.2. Merck 13.2.3. 3M 13.2.4. Cambridge Isotope Laboratories, Inc. 13.2.5. URENCO Limited 13.2.6. IsoSciences, LLC 13.2.7. Medical Isotopes, Inc. 13.2.8. Omicron Biochemicals, Inc. 13.2.9. Trace Sciences International 13.2.10. Alsachim 13.2.11. Taiyo Nippon Sanso Corporation 13.2.12. CortecNet 13.2.13. ISOFLEX 13.2.14. Huayi Isotopes Co 13.2.15. Mesbah Energy Co. 13.2.16. C/D/N/ Isotope Inc. 13.2.17. Shoko Co. Ltd. 13.2.18. Nordion Inc. 13.2.19. BOC Sciences 13.2.20. Pepscan 14. Strategic Recommendations 15. About Us & Disclaimer
SummaryThe global market for stable isotope labeled compounds is expected to grow at a steady CAGR during the forecast period. These compounds are used to check the isotope pathway during a chemical metabolism or to detect any isotopic presence in the cells. Thus, they are generally used in biomedical research and the R&D sector, which is a major factor contributing to the growth of the market. The rising cancer cases and the increasing number of pharma and biotech companies is one of the major factors for the market growth. However, the inability to buy these compounds due to their costliness is a reason which might act as a restraint to the market. Table of Contents1. Product Overview2. Research Methodology 3. Executive Summary 4. Voice of Customer 5. Global Stable Isotopes Labeled Compounds Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value & Volume 5.2. Market Share & Forecast 5.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others) 5.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others) 5.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids. NMR Solvents and Others) 5.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others) 5.2.5. By Method (Chemical, Cell-culturing) 5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others) 5.2.7. By Company (2019) 5.2.8. By Region 5.3. Market Attractiveness Index 6. Asia-Pacific Stable Isotopes Labeled Compounds Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value & Volume 6.2. Market Share & Forecast 6.2.1. By Compounds 6.2.2. By Application 6.2.3. By Substances 6.2.4. By Indication 6.2.5. By Method 6.2.6. By End-User 6.2.7. By Country 6.3. Market Attractiveness Index 6.4. Asia-Pacific: Country Analysis 6.4.1. China Stable Isotopes Labeled Compounds Market Outlook 6.4.1.1. Market Size & Forecast 6.4.1.1.1. By Value 6.4.1.2. Market Share & Forecast 6.4.1.2.1. By Compounds 6.4.1.2.2. By Application 6.4.1.2.3. By Substances 6.4.1.2.4. By Indication 6.4.1.2.5. By Method 6.4.1.2.6. By End-User 6.4.2. India Stable Isotopes Labeled Compounds Market Outlook 6.4.2.1. Market Size & Forecast 6.4.2.1.1. By Value 6.4.2.2. Market Share & Forecast 6.4.2.2.1. By Compounds 6.4.2.2.2. By Application 6.4.2.2.3. By Substances 6.4.2.2.4. By Indication 6.4.2.2.5. By Method 6.4.2.2.6. By End-User 6.4.3. Japan Stable Isotopes Labeled Compounds Market Outlook 6.4.3.1. Market Size & Forecast 6.4.3.1.1. By Value 6.4.3.2. Market Share & Forecast 6.4.3.2.1. By Compounds 6.4.3.2.2. By Application 6.4.3.2.3. By Substances 6.4.3.2.4. By Indication 6.4.3.2.5. By Method 6.4.3.2.6. By End-User 6.4.4. South Korea Stable Isotopes Labeled Compounds Market Outlook 6.4.4.1. Market Size & Forecast 6.4.4.1.1. By Value 6.4.4.2. Market Share & Forecast 6.4.4.2.1. By Compounds 6.4.4.2.2. By Application 6.4.4.2.3. By Substances 6.4.4.2.4. By Indication 6.4.4.2.5. By Method 6.4.4.2.6. By End-User 6.4.5. Singapore Stable Isotopes Labeled Compounds Market Outlook 6.4.5.1. Market Size & Forecast 6.4.5.1.1. By Value 6.4.5.2. Market Share & Forecast 6.4.5.2.1. By Compounds 6.4.5.2.2. By Application 6.4.5.2.3. By Substances 6.4.5.2.4. By Indication 6.4.5.2.5. By Method 6.4.5.2.6. By End-User 6.4.6. Australia Stable Isotopes Labeled Compounds Market Outlook 6.4.6.1. Market Size & Forecast 6.4.6.1.1. By Value 6.4.6.2. Market Share & Forecast 6.4.6.2.1. By Compounds 6.4.6.2.2. By Application 6.4.6.2.3. By Substances 6.4.6.2.4. By Indication 6.4.6.2.5. By Method 6.4.6.2.6. By End-User 7. Europe Stable Isotopes Labeled Compounds Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value & Volume 7.2. Market Share & Forecast 7.2.1. By Compounds 7.2.2. By Application 7.2.3. By Substances 7.2.4. By Indication 7.2.5. By Method 7.2.6. By End-User 7.2.7. By Country 7.3. Market Attractiveness Index 7.4. Europe: Country Analysis 7.4.1. France Stable Isotopes Labeled Compounds Market Outlook 7.4.1.1. Market Size & Forecast 7.4.1.1.1. By Value 7.4.1.2. Market Share & Forecast 7.4.1.2.1. By Product 7.4.1.2.2. By Compounds 7.4.1.2.3. By Application 7.4.1.2.4. By Substances 7.4.1.2.5. By Indication 7.4.1.2.6. By Method 7.4.1.2.7. By End-User 7.4.2. Germany Stable Isotopes Labeled Compounds Market Outlook 7.4.2.1. Market Size & Forecast 7.4.2.1.1. By Value 7.4.2.2. Market Share & Forecast 7.4.2.2.1. By Compounds 7.4.2.2.2. By Application 7.4.2.2.3. By Substances 7.4.2.2.4. By Indication 7.4.2.2.5. By Method 7.4.2.2.6. By End-User 7.4.3. United Kingdom Stable Isotopes Labeled Compounds Market Outlook 7.4.3.1. Market Size & Forecast 7.4.3.1.1. By Value 7.4.3.2. Market Share & Forecast 7.4.3.2.1. By Compounds 7.4.3.2.2. By Application 7.4.3.2.3. By Substances 7.4.3.2.4. By Indication 7.4.3.2.5. By Method 7.4.3.2.6. By End-User 7.4.4. Italy Stable Isotopes Labeled Compounds Market Outlook 7.4.4.1. Market Size & Forecast 7.4.4.1.1. By Value 7.4.4.2. Market Share & Forecast 7.4.4.2.1. By Compounds 7.4.4.2.2. By Application 7.4.4.2.3. By Substances 7.4.4.2.4. By Indication 7.4.4.2.5. By Method 7.4.4.2.6. By End-User 7.4.5. Russia Stable Isotopes Labeled Compounds Market Outlook 7.4.5.1. Market Size & Forecast 7.4.5.1.1. By Value 7.4.5.2. Market Share & Forecast 7.4.5.2.1. By Compounds 7.4.5.2.2. By Application 7.4.5.2.3. By Substances 7.4.5.2.4. By Indication 7.4.5.2.5. By Method 7.4.5.2.6. By End-User 7.4.6. Spain Stable Isotopes Labeled Compounds Market Outlook 7.4.6.1. Market Size & Forecast 7.4.6.1.1. By Value 7.4.6.2. Market Share & Forecast 7.4.6.2.1. By Compounds 7.4.6.2.2. By Application 7.4.6.2.3. By Substances 7.4.6.2.4. By Indication 7.4.6.2.5. By Method 7.4.6.2.6. By End-User 8. North America Stable Isotopes Labeled Compounds Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value & Volume 8.2. Market Share & Forecast 8.2.1. By Compounds 8.2.2. By Application 8.2.3. By Substances 8.2.4. By Indication 8.2.5. By Method 8.2.6. By End-User 8.2.7. By Country 8.3. Market Attractiveness Index 8.4. North America: Country Analysis 8.4.1. United States Stable Isotopes Labeled Compounds Market Outlook 8.4.1.1. Market Size & Forecast 8.4.1.1.1. By Value 8.4.1.2. Market Share & Forecast 8.4.1.2.1. By Compounds 8.4.1.2.2. By Application 8.4.1.2.3. By Substances 8.4.1.2.4. By Indication 8.4.1.2.5. By Method 8.4.1.2.6. By End-User 8.4.2. Mexico Stable Isotopes Labeled Compounds Market Outlook 8.4.2.1. Market Size & Forecast 8.4.2.1.1. By Value 8.4.2.2. Market Share & Forecast 8.4.2.2.1. By Compounds 8.4.2.2.2. By Application 8.4.2.2.3. By Substances 8.4.2.2.4. By Indication 8.4.2.2.5. By Method 8.4.2.2.6. By End-User 8.4.3. Canada Stable Isotopes Labeled Compounds Market Outlook 8.4.3.1. Market Size & Forecast 8.4.3.1.1. By Value 8.4.3.2. Market Share & Forecast 8.4.3.2.1. By Compounds 8.4.3.2.2. By Application 8.4.3.2.3. By Substances 8.4.3.2.4. By Indication 8.4.3.2.5. By Method 8.4.3.2.6. By End-User 9. South America Stable Isotopes Labeled Compounds Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value & Volume 9.2. Market Share & Forecast 9.2.1. By Compounds 9.2.2. By Application 9.2.3. By Substances 9.2.4. By Indication 9.2.5. By Method 9.2.6. By End-User 9.2.7. By Country 9.3. Market Attractiveness Index 9.4. South America: Country Analysis 9.4.1. Brazil Stable Isotopes Labeled Compounds Market Outlook 9.4.1.1. Market Size & Forecast 9.4.1.1.1. By Value 9.4.1.2. Market Share & Forecast 9.4.1.2.1. By Compounds 9.4.1.2.2. By Application 9.4.1.2.3. By Substances 9.4.1.2.4. By Indication 9.4.1.2.5. By Method 9.4.1.2.6. By End-User 9.4.2. Argentina Stable Isotopes Labeled Compounds Market Outlook 9.4.2.1. Market Size & Forecast 9.4.2.1.1. By Value 9.4.2.2. Market Share & Forecast 9.4.2.2.1. By Compounds 9.4.2.2.2. By Application 9.4.2.2.3. By Substances 9.4.2.2.4. By Indication 9.4.2.2.5. By Method 9.4.2.2.6. By End-User 9.4.3. Colombia Stable Isotopes Labeled Compounds Market Outlook 9.4.3.1. Market Size & Forecast 9.4.3.1.1. By Value 9.4.3.2. Market Share & Forecast 9.4.3.2.1. By Compounds 9.4.3.2.2. By Application 9.4.3.2.3. By Substances 9.4.3.2.4. By Indication 9.4.3.2.5. By Method 9.4.3.2.6. By End-User 10. Middle East and Africa Stable Isotopes Labeled Compounds Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value & Volume 10.2. Market Share & Forecast 10.2.1. By Compounds 10.2.2. By Application 10.2.3. By Substances 10.2.4. By Indication 10.2.5. By Method 10.2.6. By End-User 10.2.7. By Country 10.3. Market Attractiveness Index 10.4. MEA: Country Analysis 10.4.1. South Africa Stable Isotopes Labeled Compounds Market Outlook 10.4.1.1. Market Size & Forecast 10.4.1.1.1. By Value 10.4.1.2. Market Share & Forecast 10.4.1.2.1. By Compounds 10.4.1.2.2. By Application 10.4.1.2.3. By Substances 10.4.1.2.4. By Indication 10.4.1.2.5. By Method 10.4.1.2.6. By End-User 10.4.2. Saudi Arabia Stable Isotopes Labeled Compounds Market Outlook 10.4.2.1. Market Size & Forecast 10.4.2.1.1. By Value 10.4.2.2. Market Share & Forecast 10.4.2.2.1. By Compounds 10.4.2.2.2. By Application 10.4.2.2.3. By Substances 10.4.2.2.4. By Indication 10.4.2.2.5. By Method 10.4.2.2.6. By End-User 10.4.3. UAE Stable Isotopes Labeled Compounds Market Outlook 10.4.3.1. Market Size & Forecast 10.4.3.1.1. By Value 10.4.3.2. Market Share & Forecast 10.4.3.2.1. By Compounds 10.4.3.2.2. By Application 10.4.3.2.3. By Substances 10.4.3.2.4. By Indication 10.4.3.2.5. By Method 10.4.3.2.6. By End-User 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 13. Competitive Landscape 13.1. Competition Outlook 13.2. Players Profiled (Leading Companies) 13.2.1. PerkinElmer 13.2.2. Merck 13.2.3. 3M 13.2.4. Cambridge Isotope Laboratories, Inc. 13.2.5. URENCO Limited 13.2.6. IsoSciences, LLC 13.2.7. Medical Isotopes, Inc. 13.2.8. Omicron Biochemicals, Inc. 13.2.9. Trace Sciences International 13.2.10. Alsachim 13.2.11. Taiyo Nippon Sanso Corporation 13.2.12. CortecNet 13.2.13. ISOFLEX 13.2.14. Huayi Isotopes Co 13.2.15. Mesbah Energy Co. 13.2.16. C/D/N/ Isotope Inc. 13.2.17. Shoko Co. Ltd. 13.2.18. Nordion Inc. 13.2.19. BOC Sciences 13.2.20. Pepscan 14. Strategic Recommendations 15. About Us & Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオマス)の最新刊レポート
TechSci Research社のバイオマス分野での最新刊レポート
本レポートと同じKEY WORD(biotechnology)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/18 10:26 155.35 円 164.28 円 199.02 円 |